Niclosamide inhibits Newcastle disease virus replication in chickens by perturbing the cellular glycolysis

• Published in: Virology (New York, N.Y.) N.Y.), 2023-08, Vol.585, p.196-204
• Main Authors: Vashi, Yoya, Nehru, Ganesh, Kumar, Sachin
• Format: Article
• Language: English
• Subjects: Anti-viral; antiviral properties; Avian orthoavulavirus 1; family; Glycolysis; Newcastle disease virus; Niclosamide; poultry; RNA; therapeutics; virion; virus replication
• ISSN: 0042-6822; 1096-0341
• DOI: 10.1016/j.virol.2023.06.010

Newcastle disease virus (NDV), a member of Paramyxoviridae family, is one of the most important pathogens in poultry. To ensure optimal environments for their replication and spread, viruses rely largely on host cellular metabolism. In the present study, we evaluated the small drug molecule niclosamide for its anti-NDV activity. Our study has shown that a sublethal dose of 1 μM niclosamide could drastically reduce NDV replication. The results showed that niclosamide has antiviral activity against NDV infection during in vitro, in ovo and in vivo assays. Pharmacologically inhibiting the glycolytic pathway remarkably reduced NDV RNA synthesis and infectious virion production. Our results suggest that the effect of niclosamide on cellular glycolysis could be the possible reason for the specific anti-NDV effect. This study could help us understand antiviral strategies against similar pathogens and may lead to novel therapeutic approaches through targeted inhibition of specific cellular metabolic pathways. •Effect of niclosamide on Newcastle disease virus (NDV) replication in vitro, in ovo and in vivo.•Inhibiting glycolytic pathway reduced infectious virion production.•Plausible effect of niclosamide on cellular glycolysis.